Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant

Elio Castagnola; M. Machetti; B. Cappelli; A. C. Molinari; G. Morreale; P. Dodero; P. Tomà; M. Faraci

doi:10.1111/j.1198-743X.2004.00837.x

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant

Elio Castagnola, M. Machetti, B. Cappelli, A. C. Molinari, G. Morreale, P. Dodero, P. Tomà, M. Faraci

Research output: Contribution to journal › Article › peer-review

Abstract

Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.

Original language	English
Pages (from-to)	255-257
Number of pages	3
Journal	Clinical Microbiology and Infection
Volume	10
Issue number	3
DOIs	https://doi.org/10.1111/j.1198-743X.2004.00837.x
Publication status	Published - Mar 2004

Keywords

Amphotericin B
Bone marrow transplant
Caspofungin
Fungal pneumonia
Leukaemia
Voriconazole

ASJC Scopus subject areas

Microbiology (medical)
Microbiology
Infectious Diseases

Access to Document

10.1111/j.1198-743X.2004.00837.x

Cite this

Castagnola, E., Machetti, M., Cappelli, B., Molinari, A. C., Morreale, G., Dodero, P., Tomà, P., & Faraci, M. (2004). Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant. Clinical Microbiology and Infection, 10(3), 255-257. https://doi.org/10.1111/j.1198-743X.2004.00837.x

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant. / Castagnola, Elio; Machetti, M.; Cappelli, B.; Molinari, A. C.; Morreale, G.; Dodero, P.; Tomà, P.; Faraci, M.

In: Clinical Microbiology and Infection, Vol. 10, No. 3, 03.2004, p. 255-257.

Research output: Contribution to journal › Article › peer-review

Castagnola, E, Machetti, M, Cappelli, B, Molinari, AC, Morreale, G, Dodero, P, Tomà, P & Faraci, M 2004, 'Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant', Clinical Microbiology and Infection, vol. 10, no. 3, pp. 255-257. https://doi.org/10.1111/j.1198-743X.2004.00837.x

Castagnola E, Machetti M, Cappelli B, Molinari AC, Morreale G, Dodero P et al. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant. Clinical Microbiology and Infection. 2004 Mar;10(3):255-257. https://doi.org/10.1111/j.1198-743X.2004.00837.x

Castagnola, Elio ; Machetti, M. ; Cappelli, B. ; Molinari, A. C. ; Morreale, G. ; Dodero, P. ; Tomà, P. ; Faraci, M. / Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant. In: Clinical Microbiology and Infection. 2004 ; Vol. 10, No. 3. pp. 255-257.

@article{b17c7a5195994efc8c4ffff7fc95a92c,

title = "Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant",

abstract = "Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.",

keywords = "Amphotericin B, Bone marrow transplant, Caspofungin, Fungal pneumonia, Leukaemia, Voriconazole",

author = "Elio Castagnola and M. Machetti and B. Cappelli and Molinari, {A. C.} and G. Morreale and P. Dodero and P. Tom{\`a} and M. Faraci",

year = "2004",

month = mar,

doi = "10.1111/j.1198-743X.2004.00837.x",

language = "English",

volume = "10",

pages = "255--257",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant

AU - Castagnola, Elio

AU - Machetti, M.

AU - Cappelli, B.

AU - Molinari, A. C.

AU - Morreale, G.

AU - Dodero, P.

AU - Tomà, P.

AU - Faraci, M.

PY - 2004/3

Y1 - 2004/3

N2 - Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.

AB - Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.

KW - Amphotericin B

KW - Bone marrow transplant

KW - Caspofungin

KW - Fungal pneumonia

KW - Leukaemia

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=1642269276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642269276&partnerID=8YFLogxK

U2 - 10.1111/j.1198-743X.2004.00837.x

DO - 10.1111/j.1198-743X.2004.00837.x

M3 - Article

C2 - 15008948

AN - SCOPUS:1642269276

VL - 10

SP - 255

EP - 257

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 3

ER -

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukamia or undergoing allogeneic bone narrow transplant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this